New breast cancer drug candidate tested in healthy women first
NCT ID NCT06995482
First seen Feb 18, 2026 · Last updated May 23, 2026 · Updated 13 times
Summary
This early-stage study tests a new drug called KSHN001034 in 40 healthy postmenopausal women to see if it is safe and how the body processes it. The drug is similar to an existing breast cancer treatment, Faslodex. Participants receive either the new drug or the existing one at different doses, and researchers monitor side effects and drug levels in the blood.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY POSTMENOPAUSAL WOMEN are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Floridian Clinical Research LLC
RECRUITINGMiami Lakes, Florida, 33016, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Synergen Bio Pvt. Ltd.
RECRUITINGPune, Maharashtra, 411003, India
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.